Cutaneous leishmaniasis mimicking cutaneous lymphoma

Pires, Carla Andréa Avelar; Pereira, Nathalia Gabay; Moreira, Amanda Gabay; Sena, Julie Marie Costa; Costa, Caio César Chaves; Bastos, Thalita; Rodrigues, Fernanda do Nascimento; Faustino, Evelyn de Paiva; Silva, Jéssica Rayanne Corrêa da; Santos, Maria Amélia Lopes dos

doi:10.1016/j.idcr.2019.e00580

Cited by 2 publications

(1 citation statement)

References 11 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…21,22 Our patients with CL had a history of travel to endemic areas, providing a clue to the diagnosis, but differentials ranging from subcutaneous and deep mycosis, cutaneous tuberculosis, lymphoma, and pseudo-lymphoma should be considered. 23 Most patients presented with a prolonged duration of symptoms, and incorrect or delayed diagnosis and treatment, highlighting the need for awareness of various cutaneous presentations of this neglected tropical disease. This is especially distressing in MCL which is known to persist for years, causing destructive lesions of palate and nasal cartilage.…”

Section: Discussionmentioning

confidence: 99%

Case Report: A Single-Center Case Series on Skin Manifestations of Leishmaniasis from a Non-Endemic State in Southern India

Tharakan

Karthik

et al. 2021

The American Journal of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Leishmaniasis is endemic in the Indian subcontinent with predominance of visceral leishmaniasis (VL) due to Leishmania donovani. Cutaneous leishmaniasis (CL) is uncommon, and mucocutaneous leishmaniasis (MCL) is rarely reported in this region. Recent reports reveal a changing epidemiology and atypical manifestations. A retrospective study of 52 suspected cases with cutaneous and mucosal involvement seen from January 2008 to December 2018 in a tertiary care setting in a non-endemic state in southern India is reported. Twelve patients were confirmed to have leishmaniasis; seven had MCL, two had CL, and three had post-kala-azar dermal leishmaniasis (PKDL). All cases were male, with a median age of 41.5 years (interquartile range, 30–55.5 years), and the median duration of the disease was 6 years (interquartile range, 1–9.5 years). Patients with MCL had mucosal involvement including destructive ulcero-proliferative lesions due to delayed diagnosis; none had a history of travel to countries endemic for MCL and all were attributable to L. donovani species. On the other hand, Leishmania major which was the causative species in both CL patients was associated with travel to the Middle East. Patients with PKDL presented with multiple plaques and hypopigmented patches; one had concomitant VL and all were from endemic areas. Hitherto uncommon MCL, caused by potentially atypical variants of L. donovani, has emerged as a new manifestation of leishmaniasis in this region. A high index of suspicion based on lesions seen and history of travel combined with PCR-based diagnostics are required to confirm diagnosis for the various skin manifestations of leishmaniasis.

show abstract

Section: Discussionmentioning

confidence: 99%